Regardless of the EGFR type, 8PN reduced the viability of lung cancer cells in a dose‐dependent manner after 3 days of treatment, with IC50 values ranging from 22 to 100 μm, whereas it had no cytotoxicity in mouse splenocytes (Fig. S1C). Here, EGFR is linked to lung carcinoma.